Abstract
Clostridioides difficile (CD) is a spore-forming bacterium that causes life-threatening intestinal infections in humans. Although formerly regarded as exclusively nosocomial, there is increasing genomic evidence that person-to-person transmission accounts for only <25% of cases, supporting the culture-based hypothesis that foods may be routine sources of CD-spore ingestion in humans.
To synthesize the evidence on the risk of CD exposure via foods, we conducted a systematic review and meta-analysis of studies reporting the culture prevalence of CD in foods between January 1981 and November 2019. Meta-analyses, risk-ratio estimates, and meta-regression were used to estimate weighed-prevalence across studies and food types to identify laboratory and geographical sources of heterogeneity.
In total, 21,886 food samples were tested for CD between 1981 and 2019 (232 food-sample-sets; 79 studies; 25 countries). Culture methodology, sample size and type, region, and latitude were significant sources of heterogeneity (p<0.05). Although non-strictly-anaerobic methods were reported in some studies, and we confirmed experimentally that improper anaerobiosis of media/sample-handling affects CD recovery in agar (Fisher, p<0.01), most studies (>72%) employed the same (one-of-six) culture strategy. Because the prevalence was also meta-analytically similar across six culture strategies reported, all studies were integrated using three meta-analytical methods. At the study level (n=79), the four-decade global cumulative-prevalence of CD in the human diet was 4.1% (95%CI=-3.71, 11.91). At the food-set level (n=232), the weighted prevalence ranged between 4.5% (95%CI=3-6%; all studies) and 8% (95%CI=7-8%; only CD-positive-studies). Risk-ratio ranking and meta-regression showed that milk was the least likely source of CD, while seafood, leafy green vegetables, pork, and poultry carried higher risks (p<0.05). Across regions, the risk of CD in foods for foodborne exposure reproducibly decreased with Earth latitude (p<0.001).
In conclusion, CD in the human diet is a global nonrandom-source of foodborne exposure that occurs independently of laboratory culture methods, across regions, and at variable level depending on food type and latitude. The latitudinal trend (high CD-food-prevalence towards tropic) is unexpectedly inverse to the epidemiological observations of CD-infections in humans (frequent in temperate regions). Findings suggests the plausible hypothesis that ecologically-richer microbiomes in the tropic might protect against intestinal CD colonization/infections despite CD ingestion.
Competing Interest Statement
The authors declare that there is no conflict of interests regarding the publication of this paper. A.D. has received research support from Clorox and is on the advisory board of Ferring Pharmaceuticals, unrelated to the study.
Clinical Trial
This is not a clinical trial. This is systematic review of the literature on food safety that was recommended for transfer from bioRxiv (MS: 840249), who stated that medRxiv would be a better fit. Please consider our meta analysis for publication as preprint in medRxiv. In food safety systematic reviews, there is no official registries to report reviews, however we followed health science standards.
Funding Statement
Study was conducted with internal funds allocated to the corresponding authors. SI is an Assistant professor of Human Nutrition and Food Microbiology, the official Food Safety State Specialist for the state of Ohio in the USA, and is a current Expert consultant on food safety for the Food Agricultural Organization of the United Nations. NB received support from the Fulbright as a senior scholar and visiting professor in mathematics at the University of North Carolina. ARP receives support from the National Institutes of Health via grants R21 and R01 subaward mechanism, and is the Director of the Germ Free and Gut Microbiome Core at the Digestive Diseases Research Institute and is the Technical Director of the Mouse Models Core at the NIH Silvio O Conte Cleveland Digestive Diseases Research Core Center.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interests The authors declare that there is no conflict of interests regarding the publication of this paper. A.D. has received research support from Clorox and is on the advisory board of Ferring Pharmaceuticals, unrelated to the study.
Data Availability
Data Availability and Open Access. All data, easily extractable from the manuscripts listed in the Supplementary References, will be made available by the corresponding authors upon reasonable request. This article is intended for publication as open access under the terms of a Creative Commons Attribution- International License.
